144 related articles for article (PubMed ID: 12864977)
1. Modulation of type I IL-1 receptor and IL-1 beta mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse.
Pournajafi Nazarloo H; Takao T; Taguchi T; Ito H; Hashimoto K
J Neuroimmunol; 2003 Jul; 140(1-2):102-8. PubMed ID: 12864977
[TBL] [Abstract][Full Text] [Related]
2. Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress.
Pournajafi Nazarloo H; Takao T; Nanamiya W; Asaba K; De Souza EB; Hashimoto K
Brain Res; 2001 May; 902(1):119-26. PubMed ID: 11376601
[TBL] [Abstract][Full Text] [Related]
3. Pituitary-adrenal axis regulation in CRH-deficient mice.
Muglia LJ; Bethin KE; Jacobson L; Vogt SK; Majzoub JA
Endocr Res; 2000 Nov; 26(4):1057-66. PubMed ID: 11196416
[TBL] [Abstract][Full Text] [Related]
4. Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart.
Pournajafi Nazarloo H; Tanaka Y; Dorobantu M; Hashimoto K
Regul Pept; 2003 Sep; 115(2):131-8. PubMed ID: 12972328
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation.
Bethin KE; Vogt SK; Muglia LJ
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9317-22. PubMed ID: 10922080
[TBL] [Abstract][Full Text] [Related]
6. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection.
Takao T; Hashimoto K; De Souza EB
Brain Behav Immun; 1995 Dec; 9(4):276-91. PubMed ID: 8903846
[TBL] [Abstract][Full Text] [Related]
7. Modulation of type I interleukin-1 receptor messenger RNA followed by one and repeated endotoxin treatment in the mouse.
Nagano I; Takao T; Nanamiya W; Hashimoto K
J Neuroimmunol; 2000 Jun; 105(2):154-60. PubMed ID: 10742557
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-1(beta) in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte apoptosis in mice.
Islam Z; Pestka JJ
Toxicol Sci; 2003 Jul; 74(1):93-102. PubMed ID: 12773775
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone regulates IL-6 expression during inflammation.
Venihaki M; Dikkes P; Carrigan A; Karalis KP
J Clin Invest; 2001 Oct; 108(8):1159-66. PubMed ID: 11602623
[TBL] [Abstract][Full Text] [Related]
10. Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways.
Mouihate A; Galic MA; Ellis SL; Spencer SJ; Tsutsui S; Pittman QJ
J Neurosci; 2010 Jun; 30(23):7975-83. PubMed ID: 20534845
[TBL] [Abstract][Full Text] [Related]
11. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic pituitary adrenal axis and immune responses to endotoxin in rats with chronic adjuvant-induced arthritis.
Grinevich V; Harbuz M; Ma XM; Jessop D; Tilders FJ; Lightman SL; Aguilera G
Exp Neurol; 2002 Nov; 178(1):112-23. PubMed ID: 12460613
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of one and repeated endotoxin treatment on pituitary- adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha.
Nagano I; Takao T; Nanamiya W; Takemura T; Nishiyama M; Asaba K; Makino S; De Souza EB; Hashimoto K
Neuroimmunomodulation; 1999; 6(4):284-92. PubMed ID: 10393514
[TBL] [Abstract][Full Text] [Related]
14. CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors.
Jacobson L; Muglia LJ; Weninger SC; Pacák K; Majzoub JA
Neuroendocrinology; 2000 Feb; 71(2):79-87. PubMed ID: 10686522
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1β (IL-1β) increases pain behavior and the blood glucose level: possible involvement of glucocorticoid system.
Sim YB; Park SH; Kang YJ; Jung JS; Ryu OH; Choi MG; Choi SS; Suh HW
Cytokine; 2013 Oct; 64(1):351-6. PubMed ID: 23773309
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
Parsadaniantz SM; Batsché E; Gegout-Pottie P; Terlain B; Gillet P; Netter P; Kerdelhué B
Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide.
Venihaki M; Zhao J; Karalis KP
J Neuroimmunol; 2003 Aug; 141(1-2):3-9. PubMed ID: 12965248
[TBL] [Abstract][Full Text] [Related]
18. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors.
Schmidt ED; Aguilera G; Binnekade R; Tilders FJ
Neuroscience; 2003; 116(1):275-83. PubMed ID: 12535959
[TBL] [Abstract][Full Text] [Related]
19. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
Takemura T; Makino S; Takao T; Asaba K; Suemaru S; Hashimoto K
Brain Res; 1997 Sep; 767(2):181-91. PubMed ID: 9367246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
